Actuate Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2023 Dec2024
Operating Activities
Net Income -24.66M-24.96M
Share-based Compensation 0.42M2.00M
Gains from Investment Securities 0.08M0.11M
Cash from Operations -21.63M-21.84M
Change in Working Capital
Change in Account Payables 1.29M-1.50M
Change in Accured Expenses 1.14M2.70M
Other Working Capital Changes 0.00M0.53M
Financing Activities
Cash from Financing Activities 4.13M27.53M
Additional items
Change in Cash -17.49M5.68M
Free Cash Flow -21.63M-21.84M
Net Cash Flow -17.49M5.68M